Mike Kelliher

Insider Reports History

Location
San Diego, CA
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Mike Kelliher
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mike Kelliher:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Chief Business Officer Common Stock 364,666 $2,080,419 $5.70 20 Feb 2026 Direct
ARDELYX, INC. Chief Business Officer Stock Option (Right to Buy) 154,625 $475,644 $2.32 23 Jan 2026 Direct
CAPRICOR THERAPEUTICS, INC. Director Stock Option (Right to Buy) 15,500 05 Jan 2026 Direct

Insider Reports Filed by Mike Kelliher

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARDX ARDELYX, INC. 20 Feb 2026 3 -$56,099 4 Chief Business Officer 23 Feb 2026, 20:45
ARDX ARDELYX, INC. 23 Jan 2026 2 $0 4 Chief Business Officer 26 Jan 2026, 16:29
CAPR CAPRICOR THERAPEUTICS, INC. 05 Jan 2026 1 $0 4 Director 07 Jan 2026, 16:45
ARDX ARDELYX, INC. 21 Nov 2025 1 -$30,785 4 Chief Business Officer 25 Nov 2025, 16:38
ARDX ARDELYX, INC. 21 Aug 2025 1 -$32,132 4 Chief Business Officer 28 Aug 2025, 19:29
ARDX ARDELYX, INC. 20 May 2025 1 -$59,270 4 Officer 22 May 2025, 21:51
ARDX ARDELYX, INC. 25 Feb 2025 2 $0 4 Executive Vice President, Corporate Development and Strategy 27 Feb 2025, 17:57
CAPR CAPRICOR THERAPEUTICS, INC. 02 Jan 2025 3 $0 4 Director 06 Jan 2025, 19:00
ARDX ARDELYX, INC. 25 Mar 2024 2 $0 4 Executive Vice President, Corporate Development and Strategy 27 Mar 2024, 18:13
ARDX ARDELYX, INC. 25 Mar 2024 0 $0 3 Executive Vice President, Corporate Development and Strategy 27 Mar 2024, 18:11
CAPR CAPRICOR THERAPEUTICS, INC. 02 Jan 2024 4 $0 4 Director 04 Jan 2024, 17:15
CAPR CAPRICOR THERAPEUTICS, INC. 01 Sep 2023 1 $0 4 Director 06 Sep 2023, 18:03
CAPR CAPRICOR THERAPEUTICS, INC. 01 Sep 2023 0 $0 3 Director 06 Sep 2023, 18:01
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .